Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test

NCT04221906 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG: BOS-475
DRUG: Active ingredient-free vehicle cream
DRUG: Daivonex cream (calcipotriol 0.005%)
DRUG: Betnesol-V cream (betamethasone 0.1%)

Sponsor

Boston Pharmaceuticals